Tag: CERC-501

April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
January 8, 2018

Top Pharma Stocks of 2017

INN has compiled a list of the top performing pharma stocks of 2017.
August 14, 2017

Cerecor Appoints Interim CEO

Cerecor announced the retirement of its president and CEO Dr. Uli Hacksell.
August 14, 2017

Cerecor Sells Rights of Opioid Receptor to Janssen

Cerecor sold its rights of CERC-501 to Janssen Pharmaceuticals.
May 1, 2017

Cerecor Reports New Data from CERC-501 Trial

Cerecor released clinical results from a sponsored trial on CERC-501 in treatment-resistant depression.
March 14, 2017

Cerecor Reports Financial Results For Q4 And 2016

Cerecor (NASDAQ:CERC) posted their financial results for its fourth quarter and for all of 2016.